About | Citrine Investments

ABOUT CITRINE S A L

Citrine S A L is a leading technology-focused investment group that enables Israeli entrepreneurs to materialize global breakthrough technology companies.

Citrine technology funds include the management of Limited Partnerships by Citrine S A L High-Tech and Citrine S A L Biotech that operate as Managing Partners.

The partnerships are registered as Limited Partnerships with the Registrar of Partnerships in Israel and include a variety of options for investment periods, fields of expertise, risk levels, profitability levels and protections that allow the investor to diversify his investment and minimize risk.

Citrine Global Corp. (OTCQB: CTGL):

Citrine Global, Corp. (OTCQB: CTGL) (“Citrine Global”) develops strategic solutions for technology industries with global growth potential in the high-tech and biotech fields, which include supportive environments that combine, among other things, entrepreneurship and the establishment of innovation centers for production, operations, R&D, marketing, export, assistance in building strategy for realizing the potential, and more.

Our focus areas:

medical devices
digital health
cannabis technologies
wellness solutions
personalized medicine
block chain solutions
biotechnology
diagnosis/prevention
clean-tech
green energy
cyber technology
Media
Internet of Things

Citrine is part of:

• WealthStone Group, that specializes in Alternative Investment in various fields , Hedge Funds , Real-estate and Technology

• Neto Finance , one of the largest insurance & finance adviser firms in Israel managing 7B NIS for private client & investors.

In the past 5 years, the group has raised over $300M from Israeli private investors setting up ~70 partnerships in various fields.

The group targets to manage in the next 7 years $1B Dollar for private & international investors.